Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Find out what would be a good investment for young adults and kickstart your investment journey with confidence.
21,907 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Thursday brought a lift to D-Wave stock as a quarterly momentum signal emerged. This guide breaks down the catalysts ...
Chinese shoppers are spending again, but not with the old urgency. A surge in savings and rising gold demand signals ...
State Farm plans to issue about $100 per vehicle to nearly 50 million auto policyholders as a one-time dividend total...
A rising productivity framework argues that some workplace tasks look busy but deliver little real value. This could ...
Volatile markets push cautious traders toward targeted bets. This piece highlights three ETFs that blend risk control...
Bloom Energy surges in Q4 2025 on AI-driven data-center demand, delivering record revenue and EBITDA. Plug Power turn...
As accel acel 2025 earnings loom, investors seek clarity on revenue, margins, and guidance. This guide breaks down wh...
Uber is moving away from the idea of a laid-back culture. CEO Dara Khosrowshahi asserts a relentless work ethic, even...
Claude AI projects a multi-year rally for XRP, SOL, and ADA, with end-2026 targets that would mark fresh highs amid i...
OpenAI unveils GPT-5.4, its most capable enterprise AI to date, combining advanced reasoning, coding, and autonomous ...
Google’s Gmail guru unveils a three-adopter framework for AI use, signaling a trust-first approach as Gmail rolls out...